Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers

Bladder cancer is one of the most financially burdensome cancers globally, from its diagnostic to its terminal stages. The impact it imposes on patients and the medical community is substantial, exacerbated by the absence of disease-specific characteristics and limited disease-free spans. Frequent r...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores Monar, Gabriela Vanessa, Reynolds, Thomas, Gordon, Maxie, Moon, David, Moon, Chulso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531979/
https://www.ncbi.nlm.nih.gov/pubmed/37762677
http://dx.doi.org/10.3390/ijms241814374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531979/
https://www.ncbi.nlm.nih.gov/pubmed/37762677
http://dx.doi.org/10.3390/ijms241814374

Ejemplares similares